News Could AI avert a future coronavirus pandemic? Could AI prevent future pandemics by developing an armoury of drugs that work against all coronaviruses?
News AI drug discovery firm Exscientia gets $60M cash injection UK artificial intelligence specialist Exscientia has topped up its coffers with a $60 million Series C funding round that will be used to advance projects into clinical trials.
News GSK adds to COPD pipeline as Exscientia deal bears fruit AI drug research firm Exscientia has delivered the first candidate molecule to its partner GlaxoSmithKline following an R&D tie-up signed in 2017.
News AI drug R&D firm Exscientia expands into Japan AI drug R&D firm Exscientia has announced it has expanded into Japan, after clinching a major research deal with Celgene.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
